The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance

Frontiers in Microbiology

Volumn 11, Issue , 2020, Pages

  Murray, Aimee K ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

antibiotic resistance; antibiotics; antimicrobial resistance; coronavirus; COVID 19

Indexed keywords

BIOCIDE; CARBAPENEM; MELANOCORTIN 1 RECEPTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; AWARENESS; BACTERIAL INFECTION; CLEANING; CORONAVIRUS DISEASE 2019; DECONTAMINATION; DISINFECTION; DRUG USE; ENTEROBACTERIACEAE; HUMAN; HYGIENE; INFECTION CONTROL; INFECTION PREVENTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY RATE; PANDEMIC; SECONDARY INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; TRAVEL; VIRUS TRANSMISSION;

EID: 85085359868     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2020.01020     Document Type: Article

References (32)

1. Baron S. A., Devaux C., Colson P., Raoult D., Rolain J. M., (2020). Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? Int. J. Antimicrob. Agents. 55:105944. 10.1016/j.ijantimicag.2020.10594432179150
2. Buffet-Bataillon S., Tattevin P., Bonnaure-Mallet M., Jolivet-Gougeon A., (2012). Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds–a critical review. Int. J. Antimicrob. Agents. 39, 381–389. 10.1016/j.ijantimicag.2012.01.01122421329
3. Canton R., Coque T. M., (2006). The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9, 466–475. 10.1016/j.mib.2006.08.011
4. Cantón R., González-Alba J. M., Galán J. C., (2012). CTX-M enzymes: origin and diffusion. Front. Microbiol. 3:110. 10.3389/fmicb.2012.0011022485109
5. Cascella M., Rajnik M., Cuomo A., Dulebohn S. C., Di Napoli R., (2020). Features, Evaluation and Treatment Coronavirus (COVID-19). (Treasure Island, FL: StatPearls Publishing).
6. Castanheira M., Griffin M. A., Deshpande L. M., Mendes R. E., Jones R. N., Flamm R. K., (2016). Detection of mcr-1 among Escherichia coli clinical isolates collected worldwide as part of the SENTRY antimicrobial surveillance program in 2014 and 2015. Antimicrob. Agents Chemother. 60, 5623–5624. 10.1128/aac.01267-1627401568
7. ECDC (2020). Situation Update Worldwide, as of 24 April 2020. (ECDC).
8. HM Government (2017). National Risk Register of Civil Emergencies, 2015 edition. London: Civil Office.
9. HM Government (2020a). Guidance on COVID-19: Interim Guidance for Primary Care. HRM Government. Available online at: https://www.gov.uk/government/publications/wn-cov-guidance-for-primary-care/wn-cov-interim-guidance-for-primary-care (accessed February 19, 2020).
10. HM Government (2020b). COVID-19 Guidance for Infection Prevention and Control in Healthcare Settings. Adapted from Pandemic Influenza: Guidance for Infection prevention and Control in Healthcare Settings, Vol. 1. DHSC; PHW; PHA; HPS; PHE.
11. Humeniuk C., Arlet G., Gautier V., Grimont P., Labia R., Philippon A., (2002). Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother. 46, 3045–3049. 10.1128/aac.46.9.3045-3049.200212183268
12. IACG (2019). No Time to Wait: Securing the Future From Drug-Resistant Infections. Report to the Secretary-General of the United Nations. (IACG).
13. Kim H., (2020). Outbreak of novel coronavirus (COVID-19): what is the role of radiologists? Eur. Radiol. 18:1–2. 10.1007/s00330-020-06748-2
14. Lai C. C., Shih T. P., Ko W. C., Tang H. J., Hsueh P. R., (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrobial. Agents. 55:105924. 10.1016/j.ijantimicag.2020.10592432081636
15. Levy S. B., (2002). Active efflux, a common mechanism for biocide and antibiotic resistance. Symp. Ser. Soc. Appl. Microbiol. 31, 655-715. 10.1046/j.1365-2672.92.5s1.4.x
16. Li B., Du P., Du Y, Sun H., Zhang P., Wan Y., et al. (2019). Detection of plasmid-mediated tigecycline-resistant gene tet(X4) in Escherichia coli from pork, Sichuan and Shandong Provinces, China, February 2019. Euro Surveill. 24:1900340. 10.2807/1560-7917.ES.2019.24.25.1900340
17. Liang Z., Li L., Wang Y., Chen L., Kong X., Hong Y., et al. (2011). Molecular basis of NDM-1, a new antibiotic resistance determinant. PLoS ONE 6:e23606. 10.1371/journal.pone.002360621887283
18. Liu Y. Y., Wang Y., Walsh T. R., Yi L. X., Zhang R., Spencer J., et al. (2016). Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 16, 161–168. 10.1016/s1473-3099(15)00424-726603172
19. Maillard J. Y., (2005). Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems. Ther. Clin. Risk Manag. 1, 307–20. 18360573
20. McBain A. J., Rickard A. H., Gilbert P., (2002). Possible implications of biocide accumulation in the environment on the prevalence of bacterial antibiotic resistance. J. Ind. Microbiol. Biotechnol. 29, 326–30. 10.1038/sj.jim.700032412483474
21. Murray A. K., Zhang L., Yin X., Zhang T., Buckling A., Snape J., et al. (2018). Novel insights into selection for antibiotic resistance in complex microbial communities. mBio. 9:e00969–18. 10.1128/mBio.00969-1830042197
22. NICE (2018). NICE Impact on Antimicrobial Resistance. Available online at: https://www.nice.org.uk/media/default/about/what-we-do/into-practice/measuring-uptake/niceimpact-antimicrobial-resistance.pdf
23. Nordmann P., Poirel L., Walsh T. R., Livermore D. M., (2011). The emerging NDM carbapenemases. Trends Microbiol. 19, 588–595. 10.1016/j.tim.2011.09.00522078325
24. Olson A. B., Silverman M., Boyd D. A., McGeer A., Willey B. M., Pong-Porter V., et al. (2005). Identification of a progenitor of the CTX-M-9 group of extended-spectrum beta-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrob. Agents Chemother. 49, 2112–2115. 10.1128/aac.49.5.2112-2115.200515855541
25. O'Neill (2014). Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. O'Neill Report Wellcome Trust. Review on Antimicrobial Resistance. (O'Neill).
26. ÖstholmBalkhed Å., Tärnberg M., Nilsson M., Nilsson L. E., Hanberger H., Hällgren A., et al. (2018). Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - a one year follow-up study. PLoS ONE.13:e0205504. 10.1371/journal.pone.020550430356258
27. Pal C., Bengtsson-Palme J., Kristiansson E., Larsson D. G., (2015). Co-occurrence of resistance genes to antibiotics, biocides and metals reveals novel insights into their co-selection potential. BMC Genomics. 16:964. 10.1186/s12864-015-2153-526576951
28. Ruan Z., Feng Y., (2016). BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res. 44:D682–D687. 10.1093/nar/gkv100426433226
29. Webber M. A., Whitehead R. N., Mount M., Loman N. J., Pallen M. J., Piddock L. J., (2015). Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure. J. Antimicrobial. Chemotherapy. 70:2241–8. 10.1093/jac/dkv10925953808
30. WHO (2009). Pandemic Influenza Preparedness and Response: A WHO Guidance Document. (WHO).
31. WHO (2015). Antibiotic Resistance: Multi-country Public Awareness Survey. Geneva: WHO. Available online at: https://apps.who.int/iris/bitstream/handle/10665/194460/9789241509817_eng.pdf;jsessionid=1CE653DEFA6FD52A298091F0633B9E87?sequence=1
32. Xu X. W., Wu X. X., Jiang X. G., Xu K. J., Ying L. J., Ma C. L., et al. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 368:m606. 10.1136/bmj.m60632075786